Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

Advertisement

Experimental & Molecular Medicine
  • View all journals
  • Search
  • My Account Login
  • Content Explore content
  • About the journal
  • Publish with us
  • Sign up for alerts
  • RSS feed
  1. nature
  2. experimental & molecular medicine
  3. articles
  4. article
Implication of Egr-1 in trifluoperazine-induced growth inhibition in human U87MG glioma cells
Download PDF
Download PDF
  • Article
  • Open access
  • Published: 01 August 2004

Implication of Egr-1 in trifluoperazine-induced growth inhibition in human U87MG glioma cells

  • Soon Young Shin1,
  • Chang Gun Kim,
  • Dong Dae Hong,
  • Jung-Hye Kim &
  • …
  • Young Han Lee 

Experimental & Molecular Medicine volume 36, pages 380–386 (2004)Cite this article

  • 1262 Accesses

  • 22 Citations

  • Metrics details

Abstract

The early growth response gene-1 (Egr-1) is a tumor suppressor which plays an important role in cell growth, differentiation and apoptosis. Egr-1 has been shown to be down-regulated in many types of tumor tissues. Trifluoperazine (TFP), a phenothiazine class of antipsychotics, restored serum-induced Egr-1 expression in several cancer cell lines. We investigated the effect of Egr-1 expression on the TFP-induced inhibition of cell growth. Ectopic expression of Egr-1 enhanced the TFP-induced antiproliferative activity and downregulated cyclin D1 level in U87MG glioma cells. Our results suggest that antipsychotics TFP exhibits antiproliferative activity through up-regulation of Egr-1.

Similar content being viewed by others

Characterization of EGFR-reprogrammable temozolomide-resistant cells in a model of glioblastoma

Article Open access 31 October 2022

C3G downregulation induces the acquisition of a mesenchymal phenotype that enhances aggressiveness of glioblastoma cells

Article Open access 06 April 2021

EGFR ligand shifts the role of EGFR from oncogene to tumour suppressor in EGFR-amplified glioblastoma by suppressing invasion through BIN3 upregulation

Article 01 August 2022

Article PDF

Author information

Authors and Affiliations

  1. Institute of Natural Science and Technology, Hanyang University, Ansan Gyeonggi-do, 426-791, South Korea

    Soon Young Shin

Authors
  1. Soon Young Shin
    View author publications

    Search author on:PubMed Google Scholar

  2. Chang Gun Kim
    View author publications

    Search author on:PubMed Google Scholar

  3. Dong Dae Hong
    View author publications

    Search author on:PubMed Google Scholar

  4. Jung-Hye Kim
    View author publications

    Search author on:PubMed Google Scholar

  5. Young Han Lee
    View author publications

    Search author on:PubMed Google Scholar

Rights and permissions

This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.

Reprints and permissions

About this article

Cite this article

Shin, S., Kim, C., Hong, D. et al. Implication of Egr-1 in trifluoperazine-induced growth inhibition in human U87MG glioma cells. Exp Mol Med 36, 380–386 (2004). https://doi.org/10.1038/emm.2004.50

Download citation

  • Published: 01 August 2004

  • Issue date: 01 August 2004

  • DOI: https://doi.org/10.1038/emm.2004.50

Share this article

Anyone you share the following link with will be able to read this content:

Sorry, a shareable link is not currently available for this article.

Provided by the Springer Nature SharedIt content-sharing initiative

Keywords

  • cell cycle
  • cyclin D1
  • glioma
  • trifluoperazine
  • tumor suppressor proteins

This article is cited by

  • The antipsychotic agent trifluoperazine hydrochloride suppresses triple-negative breast cancer tumor growth and brain metastasis by inducing G0/G1 arrest and apoptosis

    • Zhanzhan Feng
    • Yong Xia
    • Luoting Yu

    Cell Death & Disease (2018)

  • cAMP regulates vegetative growth and cell cycle in Candida albicans

    • Ajay Singh
    • Sadhna Sharma
    • Gopal K. Khuller

    Molecular and Cellular Biochemistry (2007)

Download PDF

Advertisement

Explore content

  • Research articles
  • Reviews & Analysis
  • News & Comment
  • Current issue
  • Collections
  • Sign up for alerts
  • RSS feed

About the journal

  • Special Feature
  • Journal Information
  • About the Editors
  • About the Partner
  • Contact
  • For Advertisers
  • Press Releases
  • Open Access Fees and Funding

Publish with us

  • For Authors & Referees
  • Language editing services
  • Submit manuscript

Search

Advanced search

Quick links

  • Explore articles by subject
  • Find a job
  • Guide to authors
  • Editorial policies

Experimental & Molecular Medicine (Exp Mol Med)

ISSN 2092-6413 (online)

ISSN 1226-3613 (print)

nature.com sitemap

About Nature Portfolio

  • About us
  • Press releases
  • Press office
  • Contact us

Discover content

  • Journals A-Z
  • Articles by subject
  • protocols.io
  • Nature Index

Publishing policies

  • Nature portfolio policies
  • Open access

Author & Researcher services

  • Reprints & permissions
  • Research data
  • Language editing
  • Scientific editing
  • Nature Masterclasses
  • Research Solutions

Libraries & institutions

  • Librarian service & tools
  • Librarian portal
  • Open research
  • Recommend to library

Advertising & partnerships

  • Advertising
  • Partnerships & Services
  • Media kits
  • Branded content

Professional development

  • Nature Awards
  • Nature Careers
  • Nature Conferences

Regional websites

  • Nature Africa
  • Nature China
  • Nature India
  • Nature Japan
  • Nature Middle East
  • Privacy Policy
  • Use of cookies
  • Legal notice
  • Accessibility statement
  • Terms & Conditions
  • Your US state privacy rights
Springer Nature

© 2025 Springer Nature Limited